Arrowstreet Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Sell |
|
|||||
|
2025
Q1 | $19.3M | Buy |
|
|||||
|
2024
Q4 | $3.4M | Sell |
|
|||||
|
2024
Q3 | $5.92M | Sell |
|
|||||
|
2024
Q2 | $20.8M | Sell |
|
|||||
|
2024
Q1 | $81.9M | Sell |
|
|||||
|
2023
Q4 | $81M | Sell |
|
|||||
|
2023
Q3 | $101M | Sell |
|
|||||
|
2023
Q2 | $198M | Sell |
|
|||||
|
2023
Q1 | $174M | Sell |
|
|||||
|
2022
Q4 | $204M | Buy |
|
|||||
|
2022
Q3 | $201M | Sell |
|
|||||
|
2022
Q2 | $266M | Sell |
|
|||||
|
2022
Q1 | $390M | Buy |
|
|||||
|
2021
Q4 | $422M | Buy |
|
|||||
|
2021
Q3 | $289M | Buy |
|
|||||
|
2021
Q2 | $153M | Buy |
|
|||||
|
2021
Q1 | $80.7M | Buy |
|
|||||
|
2020
Q4 | $2.14M | Sell |
|
|||||
|
2020
Q3 | $21.2M | Sell |
|
|||||
|
2020
Q2 | $127M | Sell |
|
|||||
|
2020
Q1 | $155M | Buy |
|
|||||
|
2019
Q4 | $127M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $4.36M | Sell |
|
|||||
|
2019
Q1 | $22.8M | Buy |
|
|||||
|
2018
Q4 | $4.03M | Sell |
|
|||||
|
2018
Q3 | $86.7M | Buy |
|
|||||
|
2018
Q2 | $62.8M | Buy |
|
|||||
|
2018
Q1 | $45.2M | Buy |
|
|||||
|
2017
Q4 | $12.9M | Sell |
|
|||||
|
2017
Q3 | $63.6M | Sell |
|
|||||
|
2017
Q2 | $96.2M | Buy |
|
|||||
|
2017
Q1 | $64.4M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $233M | Buy |
|
|||||
|
2016
Q2 | $189M | Buy |
|
|||||
|
2016
Q1 | $79.1M | Buy |
|
|||||
|
2015
Q4 | $6.91M | Sell |
|
|||||
|
2015
Q3 | $52.8M | Sell |
|
|||||
|
2015
Q2 | $83.3M | Buy |
|
|||||
|
2015
Q1 | $67.9M | Buy |
|
|||||
|
2014
Q4 | $11.9M | Buy |
|
|||||
|
2014
Q3 | $1.94M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $4.32M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $3.4M | Sell |
|
|||||
|
2013
Q2 | $11.9M | Buy |
|